The underlying securities are subject to a four month hold period from the original date of issue of the Subscription Receipts (hold period expires January 18, 2025 and March 1, 2025).‎ Following the ...
LifeSignals, Inc. today announced that the UbiqVue 2A Multiparameter System has received FDA Class II 510(k) clearance, ...